Literature DB >> 25586648

A secondary dengue 4 infection in a traveler returning from Haiti confirmed by virus isolation, complete genome sequencing and neutralisation assay: a brief report.

Amelie Menard1, Laetitia Ninove2, Christine Zandotti2, Isabelle Leparc-Goffart3, Raphaelle Klitting2, Cecile Baronti2, Andreas Stein1, Xavier de Lamballerie2, Rémi N Charrel4.   

Abstract

Here we report the clinical and laboratory findings of a dengue 4 virus (DENV) secondary infection in a patient returning from Haiti to France. The diagnostic of acute DEN-4 virus infection was demonstrated by (i) the presence of DEN-4 RNA in two successive serum samples, (ii) the isolation of a DEN-4 virus in Vero cells and subsequent identification of subtype IIb through complete genome sequencing, (iii) the presence of dengue NS1 antigen, (iv) the seroconversion with detection of dengue IgM in the second serum while negative in the first serum. The diagnosis of secondary dengue episode was demonstrated by (i) the presence of dengue IgG in the early serum, and (ii) the demonstration that neutralising antibodies against DEN-3 were present at the acute stage of the disease. Next-generation sequencing has a primary role to play in phylogeographic studies including database sequences, sequences from imported cases, and sequences from autochthonous cases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autochthonous; Fever; Flavivirus; Imported; Traveler

Mesh:

Substances:

Year:  2015        PMID: 25586648     DOI: 10.1016/j.tmaid.2014.12.009

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  1 in total

1.  Imported Chikungunya fever case in Greece in June 2014 and public health response.

Authors:  Sotirios Tsiodras; Danai Pervanidou; Elpida Papadopoulou; Dimitra Kavatha; Agoritsa Baka; George Koliopoulos; Evangelos Badieritakis; Antonios Michaelakis; Elpida Gavana; Eleni Patsoula; Ioannis Tsimpos; Thalia Gioksari; Evdoxia Kyriazopoulou; Annita Vakali; Androula Pavli; Helena C Maltezou; Theano Georgakopoulou; Christos Hadjichristodoulou; Jenny Kremastinou; Anna Papa
Journal:  Pathog Glob Health       Date:  2016-05-09       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.